Evaluation of the Effectiveness of Prepectoral Breast Reconstruction
NCT ID: NCT05125991
Last Updated: 2023-08-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
58 participants
INTERVENTIONAL
2019-09-03
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Local and Regional Radiotherapy for Nipple Sparing Mastectomy With Implant
NCT05213962
Pre-pectoral Versus Sub-pectoral Implant Placement in Immediate Breast Reconstruction
NCT03959709
Data Collection of Prepectoral Breast Reconstruction With Polyurethane Implantes
NCT06216106
Robotic Nipple Sparing Mastectomy with Immediate Reconstruction
NCT06860217
Pre- Versus Sub-pectoral Implant-based Breast Reconstruction After Skin-sparing Mastectomy or Nipple-sparing Mastectomy OPBC-02PREPEC
NCT04293146
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study plans to collect robust data to support the prepectoral implant placement and complete coverage of implant with acellular dermal matrix in the clinical practice.
Consequently, the project plans to move toward evidence-based medicine in breast reconstruction, avoiding marketing influences and surgeon experience as the sole source of evidence.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Prepectoral reconstruction
Prepectoral breast reconstruction with Braxon dermal matrix
Prepectoral reconstruction
Prepectoral breast reconstruction
Submuscular reconstruction
Submuscolar breast reconstruction
Submuscolar reconstruction
Submuscolar breast reconstruction
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Prepectoral reconstruction
Prepectoral breast reconstruction
Submuscolar reconstruction
Submuscolar breast reconstruction
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Not smokers
3. No vascular comorbidities (diabetic, vasculitis, coagulation disorders)
4. BMI\<30
5. CUP B-C (or mastectomy estimated weight less than 550gm)
6. Good subcutaneous layer (\>1cm on pinch test measured in upper/medial quadrant)
7. No previous breast surgery
8. No previous breast irradiation
9. Breast Ptosis 1-2 according to Renault's classification
10. DCIS tumors
11. T1 T2 pN0 breast tumor with known favourable biologic features
Exclusion Criteria
2. Positive sentinel node biopsy requiring complete axillary dissection
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
European Institute of Oncology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Francesca De Lorenzi, PhD, MD
Role: PRINCIPAL_INVESTIGATOR
European Institute of Oncology
Paolo Veronesi, MD
Role: PRINCIPAL_INVESTIGATOR
European Institute of Oncology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
European Institute of Oncology
Milan, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IEO 1002/
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.